Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
8
×
life sciences
national blog main
clinical trials
san francisco blog main
fda
national top stories
boston
deals
new york blog main
new york top stories
san francisco top stories
cancer drugs
national
startups
abbvie
acute myeloid leukemia
allergan
amgen
avexis
boulder/denver blog main
boulder/denver top stories
brian kaspar
cancer immunotherapy
centers for disease control and prevention
detroit blog main
detroit top stories
eli lilly
epigenetics
europe blog main
glaxosmithkline
immunotherapy
indiana blog main
indiana top stories
investing
ipo
mahesh karande
medical device
What
biotech
8
×
new
ipo
medicines
research
raised
therapeutics
bio
companies
company
days
developing
drug
drugs
genetic
lead
million
news
raises
roundup
abbvie
according
aims
akcea
alliance
analysis
approach
arrival
august
based
black
bring
busy
called
cancer
cases
centers
cigarettes
clinic
control
Language
unset
8
×
Current search:
biotech
×
unset
×
" boston top stories "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More